Cahill Financial Advisors Inc Pulmonx Corp Transaction History
Cahill Financial Advisors Inc
- $715 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$42.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$23.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$20.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$17.6 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$11.8 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $287M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...